Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Viral Control”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01445795
What this trial is testing

Safety Study of INX-08189, Pharmacokinetic and Pharmacodynamic With Ribavirin and Food Effect Study, in Chronically-infected Genotype 1 Hepatitis C Virus, Treatment-naïve Subjects

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 50
Early research (Phase 1)Active Not RecruitingNCT06732583
What this trial is testing

Evaluate the Safety and Immunogenicity of Ad5-105K in Adults Aged 18 to 49 Years

Who this might be right for
Tuberculosis
CanSino Biologics Inc. 36
Large-scale testing (Phase 3)Study completedNCT05056883
What this trial is testing

A Phase III Confirmatory Study of K-237

Who this might be right for
Covid19
Kowa Company, Ltd. 1,030
Large-scale testing (Phase 3)UnknownNCT05054322
What this trial is testing

FLuticasone in cOvid Treatment (FLOT)

Who this might be right for
Covid19
University of Medicine and Pharmacy at Ho Chi Minh City 500
Large-scale testing (Phase 3)WithdrawnNCT01337583
What this trial is testing

A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa

Who this might be right for
HIV Infections
International Partnership for Microbicides, Inc.
Very early researchUnknownNCT05369754
What this trial is testing

A Phase Ia Clinical Study to Evaluate the Safety, Tolerability, PK and Immunogenicity of YBSW015 in Healthy Subjects

Who this might be right for
Coronavirus Disease 2019
Yabao Pharmaceutical Group 40
Not applicableUnknownNCT05868551
What this trial is testing

Onchocerciasis-Associated Epilepsy, an Explorative Case-control Study

Who this might be right for
Onchocercal Subcutaneous NoduleEpilepsyVirus
Universiteit Antwerpen 40
Early research (Phase 1)Study completedNCT06063330
What this trial is testing

Clinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects

Who this might be right for
COVID-19Infectious DiseaseSymptomatic COVID-19 Infection Laboratory-Confirmed+1 more
Red Queen Therapeutics, Inc. 66
Post-approval studies (Phase 4)Not Yet RecruitingNCT05452928
What this trial is testing

Aciclovir Versus Placebo for HSV-2 Meningitis

Who this might be right for
Herpes Simplex 2Meningitis, Viral
Jacob Bodilsen 150
Large-scale testing (Phase 3)Study completedNCT05897541
What this trial is testing

Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection

Who this might be right for
SARS-CoV-2 Infection
Shionogi 3,701
Post-approval studies (Phase 4)Looking for participantsNCT03977753
What this trial is testing

Randomized, Placebo-controlled, Double Blind Study to Evaluate the Efficacy of 2LVERU®JUNIOR and 2LVERU® on the Treatment of Warts

Who this might be right for
Common WartFlat WartPlantar Wart
Labo'Life 162
Testing effectiveness (Phase 2)Study completedNCT00002151
What this trial is testing

A Randomized, Double-Blind Active-Controlled, Dose-Ranging Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected Patients

Who this might be right for
HIV Infections
Hoechst Marion Roussel 200
Early research (Phase 1)Study completedNCT04830800
What this trial is testing

A Phase 1/2 Safety and Immunogenicity Trial of COVID-19 Vaccine COVIVAC (Phase 1)

Who this might be right for
COVID-19 DiseaseSARS PneumoniaPneumonia, Viral+1 more
Institute of Vaccines and Medical Biologicals, Vietnam 120
Large-scale testing (Phase 3)Study completedNCT00021554
What this trial is testing

T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV Drugs

Who this might be right for
HIV Infections
Hoffmann-La Roche 525
Not applicableStudy completedNCT07447245
What this trial is testing

Parent Education About Human Papillomavirus (HPV)

Who this might be right for
HPV (Human Papillomavirus)-Associated
KTO Karatay University 64
Testing effectiveness (Phase 2)Study completedNCT05298254
What this trial is testing

A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital Herpes

Who this might be right for
Herpes Simplex
GlaxoSmithKline 505
Not applicableUnknownNCT02102451
What this trial is testing

Control and Elimination Within Australia of Hepatitis C From People Living With HIV

Who this might be right for
Hepatitis CHIVHIV-HCV Coinfection
Kirby Institute 492
Large-scale testing (Phase 3)Study completedNCT06383819
What this trial is testing

Efficacy and Safety of Longidaza® for the Treatment of Patients With Residual Changes in the Lungs After COVID-19

Who this might be right for
Post-Acute COVID-19 SyndromeLung Disease With PolymyositisFibrosis+2 more
NPO Petrovax 392
Not applicableStudy completedNCT03546530
What this trial is testing

The Curative Effect and Security of Interferon Combined Resveratrol on HBeAg Positive Chronic Hepatitis B Patients

Who this might be right for
Hepatitis BInterferon
The First Hospital of Jilin University 228
Post-approval studies (Phase 4)Study completedNCT01259453
What this trial is testing

Hepatitis B Vaccination Through Syringe Exchange Programs: A Randomized, Controlled Trial of Vaccination Schedules

Who this might be right for
Hepatitis B
Yale University 595
Next Page